Benutzerspezifische Werkzeuge

Publikationen Dr. rer. nat. Saskia Fuhrmann

Publikationen in Peer Review Journals (Stand: Dezember 2021)

Eine aktuelle Übersicht der Publikationen finden Sie unter folgenden Link (ORCID iD)


Datzmann, T., Schmitt, J., Fuhrmann, S., Roessler, M., Meier, F., Schoffer, O. (2021)
Implementation and Effectiveness of Novel Therapeutic Substances for Advanced Malignant Melanoma in Saxony, Germany, 2010–2020—Cohort Study Based on Administrative Data.
Cancers, 2021. 13(24): 6150.


Fuhrmann, S., Tesch, F., Romanos, M., Abraham, S., Schmitt, J. (2020)
ADHD in school-age children is related to infant exposure to systemic H1-antihistamines.
Allergy, 2020. 75(11): 2956-2957.


Fuhrmann, S., Koppen, A., Seeling, A., Knoth, H., Schröder, J. (2019)
Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin.
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 146: 21-27


Dissertation: Physiologically-based pharmacokinetic and mechanism-based pharmacodynamic modelling of monoclonal antibodies with a focus on tumour targeting. Universität Potsdam, 2018.

(Published online at the Institutional Repository of the University of Potsdam:


Fuhrmann, S., Kloft, C., Huisinga, W. (2017).
Impact of altered endogenous IgG on unspecific mAb clearance.
J Pharmacokinet Pharmacodyn 44(4):351-374.


W. Huisinga, S. Fuhrmann, L. Fronton, B.-F. Krippendorff, “Target-Driven Pharmacokinetics of Biotherapeutics”, in: ADME Transl. Pharmacokinet. Ther. Proteins. Appl. Drug Discov. Dev., Eds.: H. Zhou and F.-P. Theil, Wiley, 2015, pp. 197-209.